Form 4: Intuitive Surgical EVP Gary Loeb Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Gary Loeb, EVP & Chief Legal and Compliance Officer of Intuitive Surgical, sold 1,700 shares of common stock at $513.18 per share on April 25, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Gary Loeb, an Executive Vice President and Chief Legal and Compliance Officer at Intuitive Surgical Inc. (ISRG), sold 1,700 shares of the company's common stock on April 25, 2025.
- The sale was executed at a price of $513.18 per share.
- The transaction was conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
- Following the transaction, Loeb directly owns 2,245 shares of Intuitive Surgical common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale by an executive under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's performance.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. They can be part of a pre-planned diversification strategy or for personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive stock sales are a routine part of corporate governance.
- Companies like Medtronic, Stryker, and Johnson & Johnson also see regular insider trading activity.
- The use of 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the small volume of shares sold.
- The transaction is unlikely to significantly affect employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 04/25/2025 | Date of stock sale transaction |
| 11/13/2025 | Expiration date of the 10b5-1 trading plan |
Keywords
Intuitive Surgical, ISRG, Gary Loeb, stock sale, Form 4, 10b5-1 trading plan, executive compensation, securities transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.